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Background: Previous work has demonstrated that diabetic mice display exacerbated injury following myocardial ischemia-reperfusion (MI/R) 
and to be resistant to therapeutic interventions. We have reported that hydrogen sulfide (H2S) confers cardioprotection during MI/R in non-diabetic 
mice. We, therefore, set out to determine if administration of H2S at the time of reperfusion would limit the extent of myocardial injury following 
MI/R in the setting of type 2 diabetes mellitus. 
Methods: Non-diabetic and diabetic (db/db on C57BL6/J background, 10-12 wks of age) mice were subjected to 30 min of left coronary artery 
occlusion and 24 hr of reperfusion. Blood glucose levels were 394 ± 17 mg/dL in db/db mice and 138 ± 5 in non-diabetic controls (p < 0.001). 
Sodium sulfide (Na2S, 100 μg/kg) or vehicle was administered (i.v.) at the time of reperfusion. At 24 hr of reperfusion, myocardial area-at-risk (AAR) 
per left ventricle (LV) and infarct size per AAR (INF/AAR) were evaluated using Evans blue dye and TTC staining. 
Results: The AAR/LV was similar in all groups. Non-diabetic mice receiving Na2S exhibited a 56% (p < 0.001 vs. vehicle) reduction in INF/AAR, 
whereas, diabetic mice treated with Na2S only exhibited a 20% (p = 0.001 vs. vehicle) reduction in INF/AAR. 
Conclusions: These findings demonstrate the complexity of therapeutic intervention for diabetics following MI/R, as the robust cardioprotective 
effects of H2S in the non-diabetic state were found to be diminished by 64% in the diabetic state.
